Equillium Announces Poster Presentation at the Annual Meeting of the European Society for Blood and Marrow Transplantation Itolizumab in combination with systemic corticosteroids was associated ...

Phase 1a dose-escalation study data update: treatment with NXP900 resulted in exposure levels leading to robust pharmacodynamic responses across a range of tolerated doses; NXP900 has an ...

OPKO Health, Inc. (NASDAQ:OPK) is one of the Best American Penny Stocks to Buy According to Analysts. On July 8, OPKO Health, ...

The poster will focus on the company’s ongoing clinical trial, dosing and tolerability profiles, and exploratory efficacy endpoints for the use of YUTREPIA in PH-ILD patients in the ASCENT trial.

Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, will be sharing a poster ...

DiaMedica Therapeutics Announces Poster Presentation at European Stroke Organisation Conference – ESOC 2025 DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company ...

NATICK, Mass. (Aug. 11, 2016) -- The U.S. Army Natick Soldier Research, Development and Engineering Center held its 10th Annual Future Workforce Poster Presentation, showcasing science and ...

This month, Mr. Nowak will host an in-depth discussion of "Alt Fi" investment opportunities, such as merchant cash advance, Regulation A+, factoring, syndication and participations. Mr.

On January 11, the staff of the SEC’s Division of Investment Management (the “Staff”) released new guidance with respect to the current version of Rule 206(4)-1, adopted under the U.S ...

The poster presentation is available on the Presentations page of Equillium’s website under the “Itolizumab MOA” tab. About Itolizumab ...